doctitl prospect grant exclus licens acetylcholinesteras inhibitor treatment alzheim diseas cognit disord doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari notic accord 35 u c 209 c 1 37 cfr 404 7 1 nation institut health nih depart health human servic contempl grant exclus world wide licens practic invent embodi u patent 5 171 750 entitl substitut phenserin specif inhibitor acetylcholinesteras u patent applic sn 07 861 329 08 096 207 entitl phenylcarbam eserolin n1 noreserolin n1 benzylnoreserolin select inhibitor acetyl butyrylcholinesteras 07 765 766 entitl thiapysovenin carbam analog pharmaceut composit method inhibit cholinesteras 07 845 081 08 182 301 entitl carbam analog thiaphysovenin pharmaceut composit method inhibit cholinesteras 07 980 399 entitl method treat cognit disord phenserin cure inc baltimor maryland patent right invent assign unit state america prospect exclus licens royalti bear compli term condit 35 u c 209 37 cfr 404 7 prospect exclus licens may grant unless within 60 day date publish notic nih receiv written evid argument establish grant licens would consist requir 35 u c 209 37 cfr 404 7 patent patent applic disclos sever novel potent long act anti cholinesteras agent enhanc cognit highli promis drug candid treatment alzheim diseas neurolog disord well method treat condit two seri drug base loos first gener cholinesteras inhibitor physostigmin physostigmin produc demonstr small clinic improv patient alzheim diseas sever limit short half life approxim 30 minut ii high incid toxic side effect dose produc modest enzym inhibit wide accept narrow therapeut index physostigmin first gener acetylcholinesteras inhibitor limit administr adequ dose affect cognit present drug candid long act highli select acetyl ach oppos butyrylcholinesteras bche wherea ach involv metabol ach inhibit ach augment action ach therebi cholinerg function memori alzheim diseas bche propos involv lipid phospholipid metabol permeabl control transport ion across membran slow nerv conduct co inhibit bche alzheim patient consequ anticholinesteras therapi probabl clinic valu may deleteri summari address address request copi patent patent applic inquiri comment materi relat contempl licens direct mr arthur j cohn esq technolog licens specialist offic technolog transfer nation institut health 6011 execut boulevard suit 325 rockvil maryland 20892 telephon 301 4967735 facsimil 301 4020220 sign confidenti agreement requir receiv copi patent applic applic licens field use file respons notic treat object grant contempl licens written comment applic licens receiv nih within sixti 60 day notic consid date august 9 1994 address signer barbara mcgarey signer signjob deputi director offic technolog transfer signjob frfile fr doc 9419941 file 81594 8 45 frfile bill bill code 414001p bill